FINEME / COMPANY INTELLIGENCE

Company Intelligence

See what changed in published company financial reports, follow the businesses you care about, and compare a small sample from the same industry. Figures are historical—not share prices or investment recommendations.

My World ↗Compare companies ↗

01 / MY COMPANY WATCHLIST

Your followed companies

Read the latest financial periods and filing-list dates saved for companies you follow in My World.

Manage in My World →

Loading followed companies…

Followed companies and last-check comparisons are kept in this browser only. A changed badge means stored information changed since this browser last checked, not that a new filing occurred at that moment.

02 / FIND A BUSINESS

Browse the company directory

Search by name, ticker or CIK. Browse all matching listings, including companies without available analysis.

ADAPYAdaptimmune Therapeutics PLC

Inspect →

ADBEADOBE INC.

Inspect →

ADBTAdvasa Holdings, Inc.

Inspect →

ADCAGREE REALTY CORP

Inspect →

ADCTADC Therapeutics SA

Inspect →

ADDTFAddtech AB/ADR

Inspect →

ADEAAdeia Inc.

Inspect →

ADGMAdagio Medical Holdings, Inc.

Inspect →

ADIANALOG DEVICES INC

Inspect →

ADIAAdia Med, Inc.

Inspect →

ADIGADI GLOBAL DISTRIBUTION INC.

Inspect →

ADILADIAL PHARMACEUTICALS, INC.

Inspect →

03 / FINANCIAL CHANGES

NewAmsterdam Pharma Co N.V. NAMS

Pharmaceutical Preparations · SIC 2834

Full analysis →

Latest standalone quarter

Period ending 2026-09-30

Filed: 2026-11-04 · Retrieved: 2026-11-05

Compared with the same period of the prior year, ending 2025-09-30.

Revenue19.16

USD million

Change year over year: +18.82 · +5,406.9%

Net income-17.39

USD million

Change year over year: +54.62

Operating cash flow-39.77

USD million

Change year over year: -7.00

Total liabilities57.20

USD million

Change year over year: -1.15

Total assets687.99

USD million

Change year over year: -98.44

Liabilities / assets: 8.3% · Change: +0.9 percentage points

Open original filing ↗

Latest annual report

Period ending 2025-12-31

Filed: 2026-02-18 · Retrieved: 2026-11-05

Compared with the same period of the prior year, ending 2024-12-31.

Revenue22.50

USD million

Change year over year: -23.06 · -50.6%

Net income-203.82

USD million

Change year over year: +37.78

Operating cash flow-147.78

USD million

Change year over year: +10.78

Total liabilities85.85

USD million

Change year over year: -21.27

Total assets769.28

USD million

Change year over year: -95.34

Liabilities / assets: 11.2% · Change: -1.2 percentage points

Open original filing ↗

04 / INDUSTRY CONTEXT

Other companies with the same SIC classification

A small, non-ranked sample of available annual reports. Periods and business models may differ.

Company	Period ending	Revenue (USD million)	Net margin	Operating cash margin
CLNN ↗	2025-12-31	0.20	-13,086.5%	-9,273.0%
NUVB ↗	2025-12-31	62.90	-325.3%	-275.7%
DSGN ↗	2025-12-31	0.00	—	—
LYEL ↗	2025-12-31	0.04	-762,355.6%	-416,733.3%
RPRX ↗	2025-12-31	2,378.19	32.4%	104.7%
HRMY ↗	2025-12-31	868.45	18.3%	40.1%

Same SIC does not prove businesses are direct competitors. Annual periods may differ; margins may not be meaningful for every industry. Missing data are not zero and this is not a stock ranking.

05 / RECENT FINANCIAL RECORDS

Recently filed reports in the imported dataset

These are the newest filing dates found in the locally available annual and quarterly financial records. Not a real-time SEC feed; late imports and amended filings may affect what appears.

Latest standalone quarter

MH ↗

McGraw Hill, Inc.

Filed: 2026-11-05
Period ending: 2026-09-30

Latest standalone quarter

VRSK ↗

Verisk Analytics, Inc.

Filed: 2026-11-05
Period ending: 2026-09-30

Latest standalone quarter

NLOP ↗

Net Lease Office Properties

Filed: 2026-11-04
Period ending: 2026-09-30

Latest standalone quarter

MSGE ↗

Madison Square Garden Entertainment Corp.

Filed: 2026-11-04
Period ending: 2026-09-30

Latest standalone quarter

SVCO ↗

Silvaco Group, Inc.

Filed: 2026-11-04
Period ending: 2026-09-30

Latest standalone quarter

NAMS ↗

NewAmsterdam Pharma Co N.V.

Filed: 2026-11-04
Period ending: 2026-09-30

Latest standalone quarter

DEC ↗

Diversified Energy Co

Filed: 2026-11-04
Period ending: 2026-09-30

Latest standalone quarter

QDEL ↗

QuidelOrtho Corp

Filed: 2026-11-04
Period ending: 2026-09-27

Latest standalone quarter

LVWR ↗

LiveWire Group, Inc.

Filed: 2026-11-04
Period ending: 2026-09-30

Latest standalone quarter

ODTX ↗

Odyssey Therapeutics, Inc.

Filed: 2026-11-04
Period ending: 2026-09-30

Latest standalone quarter

ESAB ↗

ESAB Corp

Filed: 2026-11-04
Period ending: 2026-10-02

Latest standalone quarter

CRCL ↗

Circle Internet Group, Inc.

Filed: 2026-11-04
Period ending: 2026-09-30

Interpret the evidence carefully

Company figures are historical, sometimes revised and not necessarily from the same period. This tool does not include live stock prices, valuation, a prediction of future performance, or guaranteed real-time filing alerts. Use source filings to verify decisions.

Data sources and methodology →